Effectiveness and Safety of the Facet Fixation (FFX®) Implant in the Treatment of Degenerative Lumbar Spinal Stenosis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorSC Medica

About this trial

This is a prospective, multicentric, comparative, randomised-controlled study to evaluate the safety and efficacy of the Facet Fixation implant.

The main objective is to evaluate the effectiveness of spinal decompression associated with FFX® implants compared to spinal decompression alone in treating lumbar spinal stenosis after 2 years of treatment.

Eligibility criteria

Qualifiers

Age ≥ 50 years.

Radiographic confirmation of clinical symptoms of at least moderate degenerative spinal stenosis, of 1 to 3 adjacent segments in the L1-S1 region with the need for surgical decompression.

Radiographic confirmation of no translational instability in main segment as well as in adjacent segments (dynamic translational instability ≤3 mm);

Visual analogue scale (VAS) back pain score ≥ 50 mm (on a 100-mm scale).

Disqualifiers

Prior lumbar spine surgery.

Radiographically confirmed damage of a vertebral body (e.g., osteoporotic compression fracture or because of tumours), at any lumbar level.

Isthmic or degenerative spondylolisthesis (anterolisthesis; retrolisthesis ≥ grade II) or spondylolysis (pars fracture).

Degenerative lumbar scoliosis (Cobb angle > 25°).

Trial design

Treatments tested in this trial

  • Decompression + FFX®
  • Decompression alone

Treatment groups

320 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators